ADT
50
2
CME
64
5
MPC
44
3
NWS
60
-4
LLY
53
6
IRM
52
2
CF
56
3
MAT
41
-4
CVX
46
8
AVGO
27
2
TSCO
48
-3
KO
47
-2
SJM
45
9
CTSH
60
3
ADM
36
5
MUR
42
-2
PPG
61
-4
CMCSA
48
-2
LUV
42
-3
VTR
55
8
ADT
50
2
CME
64
5
MPC
44
3
NWS
60
-4
LLY
53
6
IRM
52
2
CF
56
3
MAT
41
-4
CVX
46
8
AVGO
27
2
TSCO
48
-3
KO
47
-2
SJM
45
9
CTSH
60
3
ADM
36
5
MUR
42
-2
PPG
61
-4
CMCSA
48
-2
LUV
42
-3
VTR
55
8
Financhill
Back

Anebulo Pharmaceuticals Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
23

ANEB
Anebulo Pharmaceuticals

Last Price:
1.47
Seasonality Move:
20.03%
Sell
19

NBY
NovaBay Pharmaceuticals

Last Price:
0.57
Seasonality Move:
1.46%
Sell
23
Anebulo Pharmaceuticals (ANEB) is a Sell

Is Anebulo Pharmaceuticals a Buy, Sell or Hold?

  • The current Anebulo Pharmaceuticals [ANEB] share price is $1.40. The Score for ANEB is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • ANEB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.61. The Score for NBY is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

ANEB Stock Price Chart

What is Anebulo Pharmaceuticals's stock price today?

  • The Anebulo Pharmaceuticals share price today is $1.40
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ANEB is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.61
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight selling pressure.

ANEB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 34.17 Sell
Chaikin Money Flow: -8205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.49 - 1.85) Sell
Bollinger Bands (100): (1.69 - 2.25) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 39.49 Sell
Chaikin Money Flow: -71560 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.63 - 0.75) Sell
Bollinger Bands (100): (0.27 - 1.35) Sell

ANEB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.49 Sell
20-day SMA: 1.63 Sell
50-day SMA: 1.84 Sell
200-day SMA: 2.28 Sell
8-day EMA: 1.48 Sell
20-day EMA: 1.6 Sell
50-day EMA: 1.77 Sell
200-day EMA: 2.14 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.68 Sell
20-day SMA: 0.71 Sell
50-day SMA: 0.67 Sell
200-day SMA: 2.28 Sell
8-day EMA: 0.67 Sell
20-day EMA: 0.68 Sell
50-day EMA: 0.72 Sell
200-day EMA: 5.47 Sell

Anebulo Pharmaceuticals Earnings Growth & ANEB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.09 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Anebulo Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):